Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 15/20 | 0.57 |
| ▸ | ITGA4 | P13612 | 15/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4949017 | 1.00 | ITGB1 (0.57) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72089 | 0.96 | ITGB1 (0.58) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72431 | 0.96 | ITGB1 (0.58) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72090 | 0.96 | ITGB1 (0.58) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72714 | 0.92 | ITGB1 (0.60) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72715 | 0.92 | ITGB1 (0.60) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72519 | 0.91 | ITGB1 (0.61) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72518 | 0.91 | ITGB1 (0.61) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL70844 | 0.90 | ITGB1 (0.62) | ITGB1ITGA4MEN1KMT2AKDM1A | |
| SCHEMBL72242 | 0.89 | ITGB1 (0.57) | ITGB1ITGA4MEN1KMT2AKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1961750-A1 | VLA-4 INHIBITORY DRUG | Daiichi Sankyo Company, Limited (JP) | 2008-08-27 | — | — | EP | disclosed |